The concentrations of norpethidine in blood were determined in panents recovering from abdominal surgery following both multiple i.m. injections (i.m. group) and the i.v. infusion (i.v. group) of pethidine. The rate of administration of pethidine averaged 25mgh~' in both groups. Concentrations of norpethidine were generally small compared with those of pethidine although the ratio of norpethidine to pethidine concentrations increased steadily over the 2 days studied. The rate of increase of blood concentration of norpethidine was 0.013 ug ml" ' h" ' in both groups of patients. No significant toxic effects were observed.
Norpethidine, a major metabolite of pethidine in man, is produced by the N-demethylation of pethidine and excreted in the urine (Mather and Meffin, 1978) . Studies in animals have suggested that norpethidine has both analgesic activity and toxic effects, being reported to have approximately half the analgesic activity and twice the toxicity of pethidine (Schaumann, 1940; Miller and Anderson, 1954; Dahlstrom et al., 1979) . Detection of norpethidine in the blood of animals and man after a single dose of pethidine, administered by a variety of routes, has been surprisingly inconsistent and, although inconsistencies in some studies can be explained by differences in the analytical methods, discrepancies have still been reported using contemporary gas chromatography (Klotz et al., 1974; Szeto and Inturrisi, 1976; Kuhnert et al., 1979) .
Blood concentrations of norpethidine associated with analgesia or toxicity have not been determined in the absence of pethidine and its effects in man remain conjectural. Nevertheless, adverse effects after the administration of pethidine in man (Miller and Jick, 1978) may be attributable, at least in part, to norpethidine, especially in patients in whom there is a decrease in the elimination of norpethidine as a result of renal failure (Szeto et al., 1977) norpethidine because of enzyme induction (Stambaugh, Wainer and Schwartz, 1978) . This study determined the rate of formation of norpethidine after multiple i.m. injections and the i.v. infusion of pethidine over 2 days following surgery and defined those norpethidine concentrations in the blood which were not associated with overt toxic sequelae.
METHODS
Blood concentrations of norpethidine were determined retrospectively from calibrated gas chromatograms obtained during studies of the analgesic response to pethidine in patients after surgery. Details of the patients and the design of the investigation were described in the original reports (Stapleton, Austin and Mather, 1979; Austin, Stapleton and Mather, 1980a) . Briefly, following abdominal hysterectomy, patients were studied for 32 h and received either pethidine 100 mg 4-hourly by injection into the buttock (i.m. group) or a continuous i.v. infusion of pethidine at an average rate of 25mgh~1 (i.v. group).
Complete data were available for six patients of the i.m. group and seven patients of the i.v. group. Norpethidine was detected but not quantitated in the blood of the remaining patients reported in those series. Norpethidine concentrations were determined using the gas chromatographic method of Mather and Tucker (1974) using lignocaine as internal standard and a nitrogen selective detector.
RESULTS

Multiple i.m. administrations
Norpethidine 0.016 |ig ml~ ' was measured in ©Macmillan Publishers Ltd 1981 the blood of one patient as early as 60 min after the initial i.m. injection. Concentrations increased steadily over the first 4 h and by the end of 8 h after the first injection (that is 4 h after the second injection) the mean (±SD) norpethidine blood concentration was 0.13+0.05 ug ml" ' (n = 6). Overnight, patients received up to three further injections (administered as required) and by 24 h after the initial injection the mean norpethidine concentration was 0.27+0.09 ug ml"'. At the end of the second day (32 h after operation) the mean concentration of norpethidine was 0.37+0.17 ugml" 1 and was still increasing. The rate of increase of norpethidine concentration was approximately linear, with a rate of 0.013 ugml" ' h" ' ( fig. 1 ). The ratio of the blood Austin, Stapleton and Mather, 1980a.) concentrations of pethidine to those of norpethidine varied markedly, because of the fluctuating concentrations of pethidine when compared with the slowly increasing concentrations of norpethidine. The maximum blood concentration of norpethidine measured in any individual was 1.13 ugml"'.
Continuous i.v. infusion
Norpethidine was detected 40 min after the start of the infusion. Mean concentrations after 8, 24 and 32 h were similar to those from i.m. injections. Again, the rate of increase of norpethidine concentrations was approximately linear, being 0.013 ugrnl" ' h~ ' (n = 7) and equal to that found in the i.m. group. After 32 h of infusion the blood concentrations of norpethidine had not reached a steady state, despite stable blood concentrations of pethidine ( fig. 2 ). 
Adverse effects
Apart from occasional nausea and vomiting, no adverse effects were recorded for any patient which could be associated directly with the pethidine or norpethidine concentrations reported here. None of the toxic effects of norpethidine reported in high-dose animal studies (convulsions, twitching, severe restlessness or respiratory depression) were evident in any patient at any time over the 32 h of the study.
DISCUSSION
Although it has not been determined specifically from direct injection, available evidence (Dahlstrom et al., 1979) suggests that the elimination rate of norpethidine is slower than that of pethidine. This is supported by our observation that in the i.v. group norpethidine concentrations were continuing to increase after the pethidine concentrations had reached a steady state. Since the absorption of pethidine into the blood after i.m. injection is variable (Austin, Stapleton and Mather, 1980a) it is not surprising to find disparate results for norpethidine after single administrations of pethidine. Such variability tends to become less significant after multiple doses and after an i.v. infusion.
However, adverse effects in man attributable directly to norpethidine continue to remain unfounded speculation although instances have been reported based on circumstantial evidence (Szeto et ah, 1977) . For example, one patient with an osteosarcoma of the sacrum received 63 doses of pethidine. He convulsed twice and blood taken before the second convulsion had a plasma norpethidine concentration of 0.67 ug ml" '. No further convulsion occurred after withdrawl of pethidine. A female with chronic renal failure who became irritable after 2 weeks of regular injections of pethidine had a plasma norpethidine concentration of 1.8 ug ml ""'. Again, adverse effects ceased on withdrawal of pethidine and with no alteration of other drug therapy. Therefore, Szeto and colleagues advised caution in the use of pethidine in patients with renal failure. However, the real cause of these effects remains unclear. Nausea, a common adverse effect of narcotic (pethidine) treatment, may result from pain itself (Anderson and Krogh, 1976 ). Thus, not only is norpethidine implicated because it accumulates with long-term administration, but so is pethidine itself and other metabolites. It is interesting to note that two subjects have received doses of norpethidine 230 and 300 mg i.v. without adverse effects being recorded (Burns et al., 1955) .
In animal studies the analgesic activity of norpethidine was one-half to two-thirds that of pethidine. During 32 h of pethidine administration in three separate studies the minimum analgesic concentration of pethidine did not change (Stapleton, Austin and Mather, 1979; Austin, Stapleton and Mather, 1980a, b) . These results suggest insignificant, if any, analgesic activity of norpethidine in man from the blood concentrations generated from these dosage regimens.
Unfortunately, evidence for the clinical effects of norpethidine in man is both ill-defined and misleading. Although no relationship between blood concentrations of norpethidine in man and either analgesic activity or toxic effects has been established either in the past or in this study, such effects of norpethidine cannot be discounted completely. Further investigations are required before toxic effects of norpethidine can be established definitively for man. These, like definitive pharmacokinetic studies, should be based on direct injection of the metabolite itself and not on circumstances arising from administration of the parent drug. 
SUMARIO
Se determinaron las concentraciones de norpetidina en la sangre de paaentes en fase de recuperacion de intervencion quirurjica abdominal, despues de multiples inyecciones intramusculares (grupo im.) y de infusiones intravenosas (grupo iv.) de petidina. El regimen de administracion de la petidina promedio 25 mg h" ' en ambos grupos. Las concentraciones de norpetidina fueron, por lo general, pequeftas en comparacion con las de petidina, aunque la razon de las concentraciones de norpetidina a petidina incremento uniformemente durante los dias en que se efectuo el estudio. El regimen de incremento de la concentracion de norpendina en la sangre fue de 0,013 |igml~' h~' para ambos grupos de pacientes. No se observaron efectos toxicos significativos.
